Uranium Royalty Corp.
Uranium Royalty Corp. Fundamental Analysis
Uranium Royalty Corp. (UROY) shows weak financial fundamentals with a PE ratio of 1502.84, profit margin of 1.35%, and ROE of 0.17%. The company generates $0.0B in annual revenue with weak year-over-year growth of 2.08%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 51.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze UROY's fundamental strength across five key dimensions:
Efficiency Score
WeakUROY struggles to generate sufficient returns from assets.
Valuation Score
WeakUROY trades at a premium to fair value.
Growth Score
WeakUROY faces weak or negative growth trends.
Financial Health Score
ExcellentUROY maintains a strong and stable balance sheet.
Profitability Score
ModerateUROY maintains healthy but balanced margins.
Key Financial Metrics
Is UROY Expensive or Cheap?
P/E Ratio
UROY trades at 1502.84 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, UROY's PEG of 9.00 indicates potential overvaluation.
Price to Book
The market values Uranium Royalty Corp. at 2.33 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 1641.83 times EBITDA. This signals the market has high growth expectations.
How Well Does UROY Make Money?
Net Profit Margin
For every $100 in sales, Uranium Royalty Corp. keeps $1.35 as profit after all expenses.
Operating Margin
Core operations generate -7.60 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.17 in profit for every $100 of shareholder equity.
ROA
Uranium Royalty Corp. generates $0.15 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Uranium Royalty Corp. generates strong operating cash flow of $31.57M, reflecting robust business health.
Free Cash Flow
Uranium Royalty Corp. generates strong free cash flow of $30.50M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.22 in free cash annually.
FCF Yield
UROY converts 3.74% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
1502.84
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
9.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.33
vs 25 benchmark
P/S Ratio
Price to sales ratio
20.85
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.001
vs 25 benchmark
Current Ratio
Current assets to current liabilities
265.74
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.002
vs 25 benchmark
ROA
Return on assets percentage
0.002
vs 25 benchmark
ROCE
Return on capital employed
-0.01
vs 25 benchmark
How UROY Stacks Against Its Sector Peers
| Metric | UROY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 1502.84 | 20.10 | Worse (Expensive) |
| ROE | 0.17% | 1093.00% | Weak |
| Net Margin | 1.35% | -30344.00% (disorted) | Weak |
| Debt/Equity | 0.00 | -0.69 (disorted) | Distorted |
| Current Ratio | 265.74 | 4.79 | Strong Liquidity |
| ROA | 0.15% | -1.00% (disorted) | Weak |
UROY outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Uranium Royalty Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.00%
Industry Style: Cyclical, Value, Commodity
DecliningEPS CAGR
198.90%
Industry Style: Cyclical, Value, Commodity
High GrowthFCF CAGR
-1159.06%
Industry Style: Cyclical, Value, Commodity
Declining